Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Insulet Corp (PODD) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8012292
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes OmniPod insulin management system, an insulin infusion system for diabetic patients. OmniPod insulin management system consists of OmniPod, a disposable insulin infusion device and the Personal Diabetes Manager, a handheld wireless device. Its OmniPod is a tubeless insulin pump that has two parts and a fully-automated cannula insertion. The company’s delivery systems business collaborates with several global pharmaceutical and biotechnology companies to adapt the OmniPod technology platform for the delivery of subcutaneous drugs across various therapeutic areas. The company markets its products in the US, Europe, and Asia through direct sales and distribution partners. Insulet is headquartered in Bedford, Massachusetts, the US.

Insulet Corp (PODD) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Corp, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Asset Transactions 14
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 14
Acquisition 15
Insulet Acquires Neighborhood Diabetes 15
Insulet Corp – Key Competitors 16
Insulet Corp – Key Employees 17
Insulet Corp – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Nov 02, 2017: Insulet Reports Third Quarter 2017 Financial Results 19
Aug 03, 2017: Insulet Reports Second Quarter 2017 Financial Results 20
May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 21
Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 22
Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 24
May 03, 2016: Insulet Reaffirms Second Quarter and Full Year 2016 Guidance 25
Apr 28, 2016: Insulet Reports First Quarter 2016 Financial Results 26
Feb 25, 2016: Insulet Reports Fourth Quarter and Full Year 2015 Financial Results 27
Corporate Communications 29
Aug 10, 2017: Insulet Appoints Michael R. Minogue and James C. Mullen to Board of Directors 29
May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 30
Oct 19, 2016: Insulet Announces Board and Management Changes 31
Feb 09, 2016: Insulet Appoints David A. Lemoine to Board of Directors 32
Other Significant Developments 33
Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Insulet Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Insulet Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Insulet Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Insulet Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Insulet Corp, Medical Devices Deals, 2011 to YTD 2017 9
Insulet Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Insulet Raises Private Placement of Senior Notes for USD345 Million 11
Insulet Prices Public Offering of 2% Notes Due 2019 for USD175 Million 12
Sinoxa Pharma Acquires Patent Rights To Omnipod Patch-Pump Technology From Insulet 14
Insulet Acquires Neighborhood Diabetes 15
Insulet Corp, Key Competitors 16
Insulet Corp, Key Employees 17
Insulet Corp, Subsidiaries 18

★海外企業調査レポート[Insulet Corp (PODD)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pioneer Distilleries Limited:企業の戦略・SWOT・財務分析
    Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report Summary Pioneer Distilleries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Rite Aid Corporation:企業のM&A・事業提携・投資動向
    Rite Aid Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rite Aid Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Rite Aid Corp (RAD):製薬・医療:M&Aディール及び事業提携情報
    Summary Rite Aid Corp (Rite Aid) is a retail drugstore chain. The company sells prescription drugs and other merchandise such as over-the-counter (OTC) medications, personal care items, health and beauty aids, cosmetics, household items, beverages, convenience foods, greeting cards, and seasonal mer …
  • Rich Products Corporation:企業の戦略・SWOT・財務情報
    Rich Products Corporation - Strategy, SWOT and Corporate Finance Report Summary Rich Products Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Austevoll Seafood Asa:企業の戦略・SWOT・財務分析
    Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report Summary Austevoll Seafood Asa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary PetroQuest Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • DHX Media Ltd.:企業のM&A・事業提携・投資動向
    DHX Media Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DHX Media Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • The Boeing Co (BA):企業の財務・戦略的SWOT分析
    The Boeing Co (BA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • ION Geophysical Corporation (IO)-石油・ガス分野:企業M&A・提携分析
    Summary ION Geophysical Corporation (ION) is a provider of seismic solutions. It offers advanced seismic data acquisition equipment, software, and seismic processing and planning services to the global oil and gas industry. The company acquires, process and interpret seismic data from seismic survey …
  • Verax Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD tech …
  • Umecrine Cognition AB-製薬・医療分野:企業M&A・提携分析
    Summary Umecrine Cognition AB (Umecrine), a subsidiary of Umecrine AB is a developer of treatments for neurological disorders in the central nervous system. The company develops pharmaceuticals for the treatment of acute life-threatening hepatic encephalopathy (HE) and long-term maintenance in minim …
  • Tosoh Corporation:企業の戦略・SWOT・財務分析
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Thai Airways International Public Co Ltd:戦略・SWOT・企業財務分析
    Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Thai Airways International Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Hunt’s Foodservice Ltd:企業の戦略・SWOT・財務情報
    Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report Summary Hunt's Foodservice Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Steinhoff International Holdings NV (SNH):企業の財務・戦略的SWOT分析
    Steinhoff International Holdings NV (SNH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • The Interpublic Group of Companies, Inc.:戦略・SWOT・企業財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • JRI Orthopaedics Ltd:製品パイプライン分析
    Summary JRI Orthopaedics Ltd (JRI), a subsidiary of Orthopaedic Research UK (ORUK), is a manufacturer of orthopaedic implants and surgical instruments. The company develops products for joint replacement, repair and reconstruction. It offers products for shoulder and knee arthoplasty, besides custom …
  • Aurora Spine Corp (ASG):企業の財務・戦略的SWOT分析
    Summary Aurora Spine Corp (Aurora) is a medical equipment provider that offers surgical tools. The company offers novel solutions in the spinal implant market through a range of minimally invasive, and regenerative spinal implant technologies. It develops and distributes spinal implant products whic …
  • HomeServe plc (HSV):企業の財務・戦略的SWOT分析
    HomeServe plc (HSV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Galapagos NV (GLPG):企業の財務・戦略的SWOT分析
    Summary Galapagos NV (Galapagos) is a biotechnology company that discovers and develops small molecule medicines for the treatment of inflammatory and fibrotic diseases. It offers Filgotinib medication targeting rheumatoid arthritis (RA). The company is investigating GLPG3667 compound against autoim …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆